QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.
about
QTc interval screening for cardiac risk in methadone treatment of opioid dependenceA systematic review of the cardiotoxicity of methadoneMethadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-upSyncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.Evaluation of QTc interval in Iranian causalities (Janbazan) of Iran-Iraq war receiving maintenance methadone treatment.Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients.Pharmacotherapy in the treatment of addiction: methadone.QTc interval prolongation in HIV-infected patients: a case-control study by 24-hour Holter ECG recording.Torsades de pointes associated with methadone and voriconazole.Torsade de pointes caused by polypharmacy and substance abuse in a patient with human immunodeficiency virus.A twist on torsade: a prolonged QT interval on methadone.Methadone for cancer pain: what have we learned from clinical studies?The successful use of parenteral methadone in a patient with a prolonged QTc interval.Perioperative and intraoperative pain and anesthetic care of the chronic pain and cancer pain patient receiving chronic opioid therapy.The Impact of Opioids on Cardiac Electrophysiology.Methadone death, dosage and torsade de pointes: risk-benefit policy implications.Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.Methadone-Associated QTc Prolongation: A Case Report and Review of the Literature.Opiates and elderly: use and side effects.Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.Atypical antipsychotic drugs and the risk of sudden cardiac death.Morphine Inhibited the Rat Neural Stem Cell Proliferation Rate by Increasing Neuro Steroid Genesis.Opioid switching to methadone: a pharmacoepidemiological study from a national prescription database.Prevalence and risk factors of prolonged QTc interval in HIV-infected patients: results of the HIV-HEART study.QTc interval prolongation in patients on long-term methadone maintenance therapy.Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
P2860
Q24201880-7894C17D-4A1E-4CBF-9C95-72286C5ABE20Q26766513-4AF2A5F7-90CA-47E4-B439-F54048F81174Q28257915-48960E0B-9497-4131-9B20-DC8633041586Q33154871-31E873FB-A04E-4605-A2D4-FBF40DF7174AQ33162180-7CA2992E-4DB3-4ECF-82E2-5FD203388856Q33166593-755C74EA-4EFE-4F84-9D1D-ADA192886E1DQ33687681-63A1C0F5-DF15-4C6A-8681-2B9120A98E09Q33835424-14ED3B6A-A32C-4095-A930-3E277E21A7D1Q33870389-3A6FFC96-652E-4011-955F-D2D04E35484FQ33878154-C8DE58FE-5E04-411E-B3D7-E6E146F190B2Q33914167-196F20B8-8EB8-451F-9420-9F8D38DF47B1Q34520166-FE884380-67E0-4FA2-BF70-8FC7928FC482Q34527805-BDBDB0C6-B7CA-48BC-A4DF-14E29FAFDAE8Q34606790-CA85DD0A-3C61-4DCA-8BA5-1129752BCA1CQ35696395-7FB4D446-77D0-410C-9978-DB2674F455EAQ36135137-5B4C6C86-2680-4C58-9EE7-7355B3AEA46EQ36202929-B70B4441-7D39-4B39-85CE-A2CAA42D1475Q36677621-C90D134C-C120-4E13-A5FB-E74D7EB268C4Q36728665-B5521515-9B23-4BD7-BC50-96D8B1F1AE3FQ36764780-72D19560-659C-43DA-B0E9-32BF424709FCQ36811537-D8B98621-FE54-4C7F-B18E-EE31332B47FEQ37101714-D1157538-F977-4CA2-829C-0E352BE93F52Q37237685-2DB3360E-02E6-4DCC-BF68-E4AFCB2E3FA3Q37248049-0BB41152-E31A-4A6C-AE59-1CE00C5F03B4Q37269776-7ED616BF-2AB0-4522-BCF5-01F7A46FFA9FQ40037212-31C649AC-EC16-4BD3-ABDA-48D1F7E7F9A3Q43938683-016F970D-9A78-4605-9C1C-C40D08434E64Q45087131-1D95FD32-70C0-4A30-B207-CFCB1AE8EB5FQ45193872-4E91A0B3-A864-4641-B5E9-A76AD876E62FQ46124515-FC6476DB-881D-41FF-B31D-2BBDF73C3921
P2860
QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
QT prolongation and Torsades d ...... us and treated with methadone.
@ast
QT prolongation and Torsades d ...... us and treated with methadone.
@en
type
label
QT prolongation and Torsades d ...... us and treated with methadone.
@ast
QT prolongation and Torsades d ...... us and treated with methadone.
@en
prefLabel
QT prolongation and Torsades d ...... us and treated with methadone.
@ast
QT prolongation and Torsades d ...... us and treated with methadone.
@en
P2093
P1476
QT prolongation and Torsades d ...... us and treated with methadone.
@en
P2093
Ferran Segura
Ignasi Anguera
Joan R Guma
Manuel Cervantes
Montserrat Sala
Olga Chapinal
P304
P356
10.1016/S0002-9149(03)00906-8
P407
P577
2003-10-01T00:00:00Z